The Analytical Scientist / Issues / 2026 / April / Honoring Chromatography Educator Peter W. Carr (1944–2025)
Voices in the Community Career Pathways Liquid Chromatography

Honoring Chromatography Educator Peter W. Carr (1944–2025)

We remember 2D-LC pioneer, devoted mentor, and “classic New Yorker,” Peter Carr 

By James Strachan 04/02/2026 3 min read

Share

Clinical Report: Honoring Chromatography Educator Peter W. Carr (1944–2025)

Overview

{'date_of_death': 'December 20, 2025'}

Background

{'examples_of_innovations': 'Add specific examples of improved assays.'}

Data Highlights

{'clarification': 'Specify the absence of numerical data is due to the source material.'}

Key Findings

{'support': 'Verify all findings are directly supported by the source.'}

Clinical Implications

{'specific_scenarios': "Include specific clinical scenarios impacted by Carr's work."}

Conclusion

{'importance': "Emphasize Carr's contributions to future chromatography developments."}

Related Resources & Content

  1. The Analytical Scientist, 2026 -- The Future of Countercurrent Chromatography
  2. The ASCO Post, 2013 -- Peter Jacobs, MD, Storied South African Hematology Pioneer, Dies
  3. The Analytical Scientist, 2026 -- Why Countercurrent Chromatography Still Matters
  4. Endocrine Society -- Primary Aldosteronism
  5. Frontiers, 2025 -- Comparative evaluation of five tacrolimus assays in transplant recipients
  6. The ASCO Post — Peter WT Pisters, MD, Honored With Top Award From Society of Surgical Oncology
  7. Primary Aldosteronism | Endocrine Society
  8. Frontiers | Comparative evaluation of five tacrolimus assays in transplant recipients: implications for optimizing therapeutic drug monitoring
  9. The importance of residual newborn screening dried blood spots, 2025 revision: A position statement of the American College of Medical Genetics and Genomics (ACMG) - PubMed

About the Author(s)

James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at. From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

More Articles by James Strachan

Recommended

Related Content

The Climate Conversation: Part Two – Michael Gonsior
Voices in the Community
The Climate Conversation: Part Two – Michael Gonsior

December 5, 2024

7 min read

In the second part of our interview, Michael Gonsior explores the pressing challenges in carbon cycle research, transformative tools and technologies, as well as analytical glimmers of hope

Charting the Contaminant Iceberg: Part One
Voices in the Community
Charting the Contaminant Iceberg: Part One

December 17, 2024

5 min read

Torsten C. Schmidt casts his eye on the contaminants of concern for the future and considers how much of the full picture current technology allows us to see – in the first of our two-part interview

The Planet Protector
Voices in the Community
The Planet Protector

December 20, 2024

10 min read

Sitting Down With… Damià Barceló Cullerès, Honorary Adjunct Professor, Chemistry and Physics Department, University of Almeria, Spain

Stefan Foser on the Future of Pharma
Voices in the Community
Stefan Foser on the Future of Pharma

November 13, 2024

6 min read

Earlier this year, Stefan Foser joined Bruker as VP of Global Pharma – following a successful career as a molecular biologist and pharma business leader. Here, he reflects on the importance of analytical technology in the post-genomic era.